New Research Shows High Accuracy of Precivity™ Blood Biomarkers in the Evaluation of Brain Amyloid i
ST. LOUIS--(BUSINESS WIRE)--#Alzheimers--C2N Diagnostics, LLC (C2N), a leader in advanced brain health diagnostics, announced new findings that its blood biomarkers Aβ42/Aβ40 (amyloid-beta) and p-tau217/np-tau217 (%p-tau217, or phosphorylated tau-217 divided by non-phosphorylated tau-217)1 are helpful in improving t...
Source: pharmiweb.com